Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 20-26

  Miyata, Masayuki ^a   Ueno, Yuji ^b   Sekine, Hideharu ^a   Ito, Osamu ^a   Sakuma, Fumitaka ^a   Koike, Hiroshi ^a   Nishio, Shintaro ^a   Nishimaki, Tomoe ^a   Kasukawa, Reiji ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Beraprost sodium; Interleukin 1; Interleukin 6; Monocrotaline; Pulmonary hypertension; Tumor necrosis factor

Indexed keywords

BERAPROST; INTERLEUKIN 1; INTERLEUKIN 6; MONOCROTALINE; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CELL DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; THROMBOCYTE AGGREGATION;

ALPROSTADIL; ANIMALS; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HYPERTENSION, PULMONARY; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MONOCROTALINE; PLATELET AGGREGATION INHIBITORS; POISONS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0030070515     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00004     Document Type: Article

References (31)

1. Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension. A pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation 1970;42:1163-84.
2. Miyata M, Kida S, Kanno T, et al. Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody. Clin Rheumatol 1990;9:56-62.
3. Miyata M, Suzuki K, Sakuma F, et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 1993;100:351-4.
4. 2 in rats and rabbits. Br J Pharmacol 1978;62:125-30.
5. Dusting GL, Moncada S, Mullane KM, Vane JR. Biotransformation of arachidonic acid in the circulation of the dog. Br J Pharmacol 1978;63:359.
6. Gryglewski JR, Korbut R, Ocetkiewicz A. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation. Nature 1978;273:765-7.
7. Moncada S, Korbut R, Bunting S, Vane JR. Prostacyclin is a circulating hormone. Nature 1978;273:767-8.
8. Jones K, Higenbottan T, Wallwork J. Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Chest 1989;96:784-9.
9. Radermacher P, Santak B, West HJ, Tarnow J, Falke KJ. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anaethesiology 1990;72:238-44.
10. 2 analogue. Jpn J Pharmacol 1987;43:81-9.
11. Nishio S, Matsuura H, Kanai N, et al. The in vivo and ex vivo anti-platelet effect of TRK-100, a stable prostacyclin analogue, in several species. Jpn J Pharmacol 1988;47:1-9.
12. Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T. Effects of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation. Arzeimittel Forschung Drug Res 1985;35:1816-8.
13. 2 analogue. Br J Pharmacol 1986;89:703-11.
14. Hayashi Y, Hussa JF, Lalich JJ. Cor pulmonale in rats. Lab Invest 1967;16:875-81.
15. Ghodsi F, Will JA. Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol 1980;240:149-55.
16. Fulton RM, Hutchinson EC, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J 1952;14:413-20.
17. Meltzer MS, Oppenheim JJ. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells. J Immunol 1977;118:77-82.
18. Matsuda T, Hirano T, Kishimoto T. Establishment of an interleukin 6 (IL-6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-lL-6 monoclonal antibodies. Eur J Immunol 1988;18:951-6.
19. Abe S, Gatanaga T, Yamazaki M. Purification of rabbit tumor necrosis factor. FASEB Lett 1985;180:203.
20. Molteni A, Ward WF, Tsao CH, Port CD, Solliday NH. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med 1984;176:88-94.
21. Johnson AR, Cambell W, Levine D, Schultz W. Influence of prostacyclin endothelial cell injury [Abstract]. Fed Proc 1983;42:772.
22. Kainoh M, Nishio S, Nakadate T. Cytoprotective action of beraprost sodium against peroxide-induced damage in vascular endothelial cells. Pharmacology 1992;45:61-70.
23. Miyata M, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, Kasukawa R. Pulmonary hypertension in rats. I. Role of bromodeoxyuridine-positive mononuclear cells and alveolar macrophages. Int Arch Allergy Immunol 1995;108:281-6.
24. Bevilacqua MP, Pober LS, Majeau GR, Gimbrone MA Jr. Interleukin (IL-1) induces biosynthesis and cell surface expression of protocoagulant activity in human vascular endothelial cells. J Exp Med 1984;160:618-23.
25. Bussolino F, Breviario F, Tetta C, Aglietta M, Mantovani A, Dejana E. Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. J Clin Invest 1986;77:2027-33.
26. Gillespie MN, Goldblum SE, Cohen DC, McClain CJ. Interleukin 1 bioactivity in the lungs of rats with monocrotaline- induced pulmonary hypertension. Proc Soc Exp Biol Med 1988;187:26-32.
27. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogata M. Interleukin-6 enhancement of interleukin-3 dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci USA 1987;84:9035-9.
28. Miyata M, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, Kasukawa R. Pulmonary hypertension in rats. II. Role of interleukin 6. Int Arch Allergy Immunol 1995;108:287-91.
29. Horvath CJ, Ferro TJ, Jesmok G, Malik A. Recombinant tumor necrosis factor increases pulmonary vascular perme- ability independent of neutrophils. Proc Natl Acad Sci USA 1988;85:9219-23.
30. Kapp GS, Kapp A, Busse R, Reide U, Interaction of granulocytes and endothelial cells upon stimulation with tumor necrosis factor-α: an ultrastructural study. Immunology 1990;181:267-75.
31. Amari T, Kubo K, Kobayashi T, Sekiguchi M. Effects of recombinant human Superoxide dismutase on tumor necrosis factor-induced lung injury in awake sheep. J Appl Physiol 1993;74:2641-8.